Table 2.
Summary of human studies to elucidate the role of PRRs in the development of T1D
PRR | Experimental subjects | Main findings | References |
---|---|---|---|
TLR | |||
TLR2 | PBMC from T1D patients and healthy controls in USA | Increased TLR2 expression in monocytes | [70] |
TLR3 | Pancreata from patients with fulminant diabetes in Japan | Confirmation of TLR3 expression in islet-infiltrating mononuclear cells | [56] |
Pancreata from human donors from Sweden or Finland infected with Coxsackie B5 virus or challenged with IFNα or IFN-γ with IL-1β | Enhanced expression of TLR3 | [58,59] | |
T1D patients and control subjects were recruited from South Africa, UK, Finland or Brazil respectively for the polymorphism screening | Significant association of SNP in theTLR3 pathways or polymorphism of the TLR3 gene with T1D. | [43,60-62] | |
T1D patients and control objects were recruited from Poland or Norway respectively to test for polymorphism screening | No significant association of TLR3 polymorphism with T1D | [63,64] | |
TLR4 | PBMC from T1D patients and healthy control subjects in the USA | Increased TLR4 expression in monocytes | [70] |
Isolated human islets obtained from non-diabetic brain-dead donors | TLR4 mRNA and surface expression were restricted to β-cells | [72] | |
TLR7 and TLR8 | DNA samples from the sib-pair families of two parents and two affected offspring from Asia Pacific, North America and Europe. | A significant association was observed between the Xp22 SNP (rs5979785) and T1D where the Xp22 SNP is located 30 kb centromeric of the functional candidate TLR8 and TLR7 genes | [99] |
TLR9 | PBMC from T1D patients, their first-degree relatives and healthy controls in Czech Republic | Stimulation with CpG 2216 induced IFN-α production that was highest in relatives of T1D patients, with the exception of autoantibody-negative relatives bearing the protective haplotypes. | [89] |
NLR | |||
NLRP3 | Genomic DNAs extracted from PBMCs from 196 Brazilian children and adolescents with T1D, 59 with CD, and 165 with AD. | NLRP3 rs10754558 SNP was significantly associated with T1D | [114] |